| 000 | nab a22 7a 4500 | ||
|---|---|---|---|
| 999 |
_c17874 _d17874 |
||
| 003 | PC17874 | ||
| 005 | 20240617134454.0 | ||
| 008 | 240617b xxu||||| |||| 00| 0 eng d | ||
| 040 | _cH12O | ||
| 041 | _aeng | ||
| 100 |
_9193 _aLagarde Sebastián, María de _eMedicina Interna |
||
| 245 | 0 | 0 |
_aHepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. _h[artículo] |
| 260 |
_bPLoS One, _c2016 |
||
| 300 | _a11(5):e0155842. | ||
| 500 | _aFormato Vancouver: Neukam K, Espinosa N, Collado A, Delgado Fernández M, Jiménez Aguilar P, Rivero Juárez A et al; hEPAtic Study Group. Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. PLoS One. 2016 May 19;11(5):e0155842. | ||
| 501 | _aPMID: 27195797 PMC4873169 | ||
| 504 | _aContiene 24 referencias | ||
| 520 | _aNo abstract available | ||
| 710 |
_96 _aServicio de Medicina Interna |
||
| 856 |
_uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873169/pdf/pone.0155842.pdf _yAcceso libre |
||
| 942 |
_2ddc _cART _n0 |
||